Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Multiple Sclerosis Treatment Shows Promising Results Unveiled By Medical Company

Breakthrough in Multiple Sclerosis Treatment: Clene’s CNM-Au8® Shows Promising Results.
In a significant development for the multiple sclerosis (MS) community, Clene Inc. recently unveiled the results of its Phase 2 VISIONARY-MS long-term extension study at the prestigious 2024 American Academy of Neurology (AAN) Annual Meeting. The findings are nothing short of groundbreaking, demonstrating substantial evidence that CNM-Au8®, an investigational therapy, not only aids in the repair and remyelination of damaged neurons but also improves vision and cognition in MS patients. $Clene(CLNN.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3726 Views
Comment
Sign in to post a comment
    121Followers
    0Following
    267Visitors
    Follow